TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target

Benzinga · 1d ago
TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $135 price target.